Traws Pharma (TRAW.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov14

Traws Pharma released FY2025 Q3 earnings on November 13 (EST), actual revenue USD 0 (forecast USD 60K), actual EPS USD -0.3441 (forecast USD -9.16)

04:00

Traws Pharma released FY2025 9 Months earnings on November 13 (EST), actual revenue USD 2.79 M, actual EPS USD 1.6358

04:00

Oct30

Traws Pharma Extends Contracts with ChemDiv and Expert Systems to Support Ratutrelvir Clinical Development

16:00

Oct22

Traws Pharma Initiates Phase 2 Clinical Trial for Ratutrelvir

22:40

Oct14

Traws Pharma Initiates Phase II Clinical Trials for Ratutrelvir

11:03

Aug14

Traws Pharma released FY2025 Q2 earnings on August 14 During-Market EST, actual revenue USD 2.733 M (forecast USD 60 K), actual EPS USD -0.1571 (forecast USD -8.75)

20:00

Schedules & Filings

Schedules

Filings

Nov13

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -3.035 M, EPS -0.3441

Aug14

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 2.733 M, Net Income -625 K, EPS -0.1099

May15

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 57 K, Net Income 15.08 M, EPS 2.0899

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More